Hemington Wealth Management Amneal Pharmaceuticals, Inc. Transaction History
Hemington Wealth Management
- $398 Million
- Q4 2024
A detailed history of Hemington Wealth Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 96 shares of AMRX stock, worth $794. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96
Previous 340
71.76%
Holding current value
$794
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$123 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$102 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$93.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$88.8 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$74.4 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.25B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...